ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
FirebrickPharma
|
68 |
18K |
1 |
15:09 |
15:09 |
ASX - By Stock
|
68
|
18K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Composition Patent Granted in South Africa
|
|
FirebrickPharma
|
5 |
1.2K |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
5
|
1.2K
|
8
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Cleansing Notice
|
|
FirebrickPharma
|
2 |
680 |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2
|
680
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Nasal Spray Launch in the USA
|
|
FirebrickPharma
|
68 |
18K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
68
|
18K
|
7
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Appendix 4D & Half-Year Financial Report to 31 December 2023
|
|
FirebrickPharma
|
10 |
3.2K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
10
|
3.2K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Appendix 4D & Half-Year Financial Report to 31 December 2023
|
|
FirebrickPharma
|
10 |
3.2K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
10
|
3.2K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Christmas Wish of Releasing Positive Announcement before Christmas
|
|
FirebrickPharma
|
26 |
7.6K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
26
|
7.6K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Christmas Wish of Releasing Positive Announcement before Christmas
|
|
FirebrickPharma
|
26 |
7.6K |
5 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
26
|
7.6K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Christmas Wish of Releasing Positive Announcement before Christmas
|
|
FirebrickPharma
|
26 |
7.6K |
6 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
26
|
7.6K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine COVID-19 Patent Granted in South Africa
|
|
FirebrickPharma
|
16 |
4.1K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
16
|
4.1K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine COVID-19 Patent Granted in South Africa
|
|
FirebrickPharma
|
16 |
4.1K |
4 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
16
|
4.1K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine COVID-19 Patent Granted in South Africa
|
|
FirebrickPharma
|
16 |
4.1K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
16
|
4.1K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Investor Update
|
|
FirebrickPharma
|
37 |
10K |
4 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
37
|
10K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Investor Update
|
|
FirebrickPharma
|
37 |
10K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
37
|
10K
|
9
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Investor Update
|
|
FirebrickPharma
|
37 |
10K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
37
|
10K
|
9
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Investor Update
|
|
FirebrickPharma
|
37 |
10K |
19 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
37
|
10K
|
19
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
FirebrickPharma
|
29 |
9.1K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
29
|
9.1K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
FirebrickPharma
|
29 |
9.1K |
4 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
9.1K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
FirebrickPharma
|
90 |
34K |
14 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
90
|
34K
|
14
|
|
ASX - By Stock
|
FRE |
Re:
After approval
|
|
FirebrickPharma
|
22 |
5.1K |
6 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
22
|
5.1K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
After approval
|
|
FirebrickPharma
|
22 |
5.1K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
22
|
5.1K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
5 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
25
|
8.4K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
9 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
25
|
8.4K
|
9
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
3 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
25
|
8.4K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.4K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
3 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.4K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.4K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
FirebrickPharma
|
25 |
8.4K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.4K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Covid-19 Trial Achieves Primary Endpoint
|
|
FirebrickPharma
|
7 |
1.8K |
8 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
7
|
1.8K
|
8
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Update on AAT Process
|
|
FirebrickPharma
|
7 |
2.0K |
10 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
7
|
2.0K
|
10
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Update on AAT Schedule
|
|
FirebrickPharma
|
4 |
1.8K |
6 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
4
|
1.8K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Update on AAT Schedule
|
|
FirebrickPharma
|
4 |
1.8K |
0 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Raises $1 million via Placement
|
|
FirebrickPharma
|
32 |
10K |
8 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
32
|
10K
|
8
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Pharma Investor Update on Key Projects
|
|
FirebrickPharma
|
4 |
1.5K |
6 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
4
|
1.5K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine AAT Appeal Timetable
|
|
FirebrickPharma
|
6 |
1.8K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
6
|
1.8K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine AAT Appeal Timetable
|
|
FirebrickPharma
|
6 |
1.8K |
5 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
6
|
1.8K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Raises $1 million via Placement
|
|
FirebrickPharma
|
32 |
10K |
6 |
21/05/23 |
21/05/23 |
ASX - By Stock
|
32
|
10K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Raises $1 million via Placement
|
|
FirebrickPharma
|
32 |
10K |
6 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
32
|
10K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Letter to Shareholders & Notice of GM & Proxy Form
|
|
FirebrickPharma
|
3 |
1.1K |
3 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
3
|
1.1K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Raises $1 million via Placement
|
|
FirebrickPharma
|
32 |
10K |
9 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
32
|
10K
|
9
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Raises $1 million via Placement
|
|
FirebrickPharma
|
32 |
10K |
5 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
32
|
10K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine COVID-19 Trial Concludes Recruitment
|
|
FirebrickPharma
|
3 |
1.4K |
5 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
3
|
1.4K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Pharma's Phase 3 Trial of Nasodine Resumes
|
|
FirebrickPharma
|
3 |
1.1K |
4 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
FRE is one to watch
|
|
FirebrickPharma
|
126 |
46K |
5 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
126
|
46K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
FRE is one to watch
|
|
FirebrickPharma
|
126 |
46K |
4 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
126
|
46K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: December 2022 Quarterly Activity Report & Appendix 4C
|
|
FirebrickPharma
|
6 |
2.3K |
3 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
6
|
2.3K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Appeal Timetable Agreed at AAT Conference
|
|
FirebrickPharma
|
3 |
1.5K |
2 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Annual General Meeting Presentation
|
|
FirebrickPharma
|
4 |
1.1K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
4
|
1.1K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Annual General Meeting Presentation
|
|
FirebrickPharma
|
4 |
1.1K |
3 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
FRE is one to watch
|
|
FirebrickPharma
|
126 |
46K |
3 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
126
|
46K
|
3
|
|